Procter & Gamble Health appoints Lokesh Chandak as CFO
Lokesh Chandak will replace the current Chief Financial Officer Amit Gupta17-03-2023
17-03-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we inform you that we have been informed by our Registrars and Share Transfer Agents, Link Intime India Private Limited, about the issue of duplicate Share certificate to the shareholder mentioned in enclosed letter. We request you to take the same on record.14-03-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we inform you that we have been informed by our Registrars and Share Transfer Agents, Link Intime India Private Limited, about the issue of duplicate Share certificate to shareholder mentioned in enclosed letter.10-03-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) Of SEBI (LODR) Regulations, 2015 Compliance: Information on loss of Share Certificate28-02-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by shareholder, about the loss /misplacement of the share certificate as detailed in enclosed letter. Intimation of the same was emailed by our RTA to us on February 23, 2023. Kindly take the above on record and acknowledge the receipt.24-02-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Related Party Transactions For Six Months Ended December 31, 2022
We are enclosing herewith the Related Party Transactions for six months ended December 31, 2022. Kindly take the same on record and oblige.15-02-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our shareholder, about the loss /misplacement of the share certificate as detailed in enclosed letter. Please take note of the same and acknowledge receipt.13-02-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) Of SEBI (LODR) Regulations, 2015 Compliance: Information on loss of Share Certificate07-02-2023
Trade Spotlight | Your blueprint for Procter Gamble Health, MM Financial Services, Zydus Lifesciences today
Procter Gamble Health shares had a robust gap up opening on Monday, rising nearly 15 percent to Rs 4,703, the highest closing level since February 16, 2022. In fact, the gap up opening has helped the stock climb over all long term moving averages (50, 100 and 200 EMA). The stock has formed strong bullish candlestick pattern on the daily charts with healthy volumes.07-02-2023
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited ('The Company')
Dear Shareholder, As updated yesterday, the Board of Directors of the Company at its Meeting held on January 31, 2023, have declared an Interim dividend of Rs. 80 per equity share of face value of Rs. 10 each for Company's Financial Year 2022-23. Shareholders who are exempted from TDS provisions through any circular or notification may provide documentary evidence in relation to the same, to enable the Company in applying the appropriate TDS on Dividend payment to such shareholder. In order to enable the Company to determine and deduct appropriate TDS / Withholding Tax, shareholders are requested to submit required forms and documents for the Financial Year 2022-23 for the purpose of claiming exemption from tax deduction (duly completed and signed) on or before February 6, 2023, as per details mentioned in enclosed letter.01-02-2023